Dass-167 !new! Jun 2026

In vivo studies have also demonstrated the efficacy of DASS-167 in mouse models of SARS-CoV-2 infection. Mice treated with DASS-167 showed a significant reduction in viral titers and lung inflammation compared to vehicle-treated controls. These findings suggest that DASS-167 has the potential to be developed as a therapeutic agent for the treatment of COVID-19.

The DASS-167 is a self-report questionnaire consisting of 167 items, divided into three subscales: DASS-167

The DASS-167 seems to be a less commonly referenced assessment tool compared to the well-established DASS-21 and DASS-42, which are widely used in psychological research and clinical settings. The standard DASS assessments are designed to measure the negative emotional states of depression, anxiety, and stress. In vivo studies have also demonstrated the efficacy